Dana-Farber/Brigham and Women’s Cancer Center Launches Online Resource for Precision Cancer Medicine
Dana-Farber/Brigham and Women’s Cancer Center (DF/BWCC), a leader in the field, has a new website to connect patients and physicians with information about precision cancer medicine.
20-May-2015 3:05 PM EDT
A novel blood test could greatly improve triage of victims of radiation accidents by rapidly predicting who will survive, who will die, and who should receive immediate medical countermeasures, according to scientists at Dana-Farber Cancer Institute.
13-May-2015 5:15 PM EDT
Research led by scientists at Dana-Farber Cancer Institute showed a new drug and a potentiating agent lengthened the lives of patients with metastatic colorectal cancer, all of whom had exhausted available standard treatments.
13-May-2015 5:00 PM EDT
Statin Drugs Can Delay Prostate Cancer Progression in Patients Receiving Androgen Deprivation Therapy, Study Shows
Men who went on cholesterol-lowering statin drugs when they began androgen deprivation therapy for prostate cancer had a longer time in which their disease was under control than did men who didn’t take statins, a clinical trial led by Dana-Farber...
6-May-2015 2:00 PM EDT
Unregulated Web Marketing of Genetic Tests for Personalized Cancer Care Raises Concerns in New Study
Websites that market personalized cancer care services often overemphasize their purported benefits and downplay their limitations, and many sites offer genetic tests whose value for guiding cancer treatment has not been shown to be clinically...
5-Mar-2015 4:00 PM EST
With March marking Colorectal Cancer Awareness Month, Dr. Jeffery Meyerhardt at Dana-Farber Cancer Institute, answers some key questions about the disease:
3-Mar-2015 2:05 PM EST
President Barack Obama is requesting an increase of $215 million in the 2016 federal budget to launch the Precision Medicine Initiative. This boost in funding for research will give genetic causes of cancer a national focus specifically around...
17-Feb-2015 3:55 PM EST
Study by Dana-Farber Cancer Institute scientists indicates that the pool of patients who can benefit from the drug olaparib is potentially much wider – and offers a ready means of identifying them.
13-Feb-2015 10:00 AM EST
With March marking Colorectal Cancer Awareness Month, here are the answers to some key questions about Colon cancer.
5-Mar-2014 5:00 PM EST
11-Nov-2013 5:00 PM EST
National Cancer Report Underscores Need for Research Funding; Dana-Farber Expert Says Scientific Advances Merit Support
17-Sep-2013 3:00 PM EDT
The Human papillomavirus, or HPV, and its link to certain cancers has been in the headlines recently, reigniting the debate whether it is appropriate to vaccinate children against the virus. Robert Haddad, MD, the disease center lead at...
7-Jun-2013 12:00 PM EDT
24-May-2013 3:00 PM EDT
Prom season and summer approach, and with them teenage girls seeking suntans. New research published in the May issue of Pediatrics finds that the number of children diagnosed with melanoma has increased an average 2% a year since the 1970s.
17-May-2013 8:00 AM EDT
The holidays are almost here and festive food is everywhere. “While these foods are delicious to eat, some have the added bonus of containing cancer-preventing nutrients,” says Stephanie Meyers, MS, RD/LDN, a nutritionist at Dana-Farber Cancer...
23-Oct-2009 1:00 PM EDT